National Institute on Drug Abuse. (September 5, 2024). Inhalants. National Institute on Drug Abuse.
Drug Enforcement Administration. (2020). Drug Fact Sheet: Inhalants. Drug Enforcement Administration.
Riegel, A. C., & French, E. D. (2008). Inhalant abuse among adolescents: neurobiological considerations. Journal of Psychoactive Drugs, 40(1), 1–11.
Becker, H. C., & Randall, C. L. (2022). The Effects of the Inhalant Toluene on Cognitive Function and Microstructure of the Prefrontal Cortex. Frontiers in Psychiatry, 13, 1106203.
University of Rochester Medical Center. (January 1, 2025). What Do You Know About Inhalant Abuse?. University of Rochester Medical Center.
MedlinePlus. (December 27, 2023). Inhalants. U.S. National Library of Medicine.
Substance Abuse and Mental Health Services Administration. (January 4, 2023). 2021 NSDUH Annual National Report. Substance Abuse and Mental Health Services Administration.
Substance Abuse and Mental Health Services Administration. (June 9, 2023). National Helpline for Mental Health, Drug, Alcohol Issues. Substance Abuse and Mental Health Services Administration.
Wu, L. T., et al. (2014). Does DSM-5 Nomenclature for Inhalant Use Disorder Improve Upon DSM-IV?. Journal of Studies on Alcohol and Drugs, 75(4), 683–692.
Drexel University. A. Substance Use Disorders Criteria. Drexel University.
Dhalla, S., et al. (2009). Inhalant Withdrawal as a Clinically Significant Feature of Inhalant Dependence. Primary Care Companion to the Journal of Clinical Psychiatry, 11(5), 198–201.
Centers for Disease Control and Prevention. (January 12, 2017). Medical Management Guidelines for Methylene Chloride. Centers for Disease Control and Prevention.
Magill, M., & Ray, L. A. (2009). Cognitive-Behavioral Treatment With Adult Alcohol and Illicit Drug Users: A Meta-Analysis of Randomized Controlled Trials. Journal of Studies on Alcohol and Drugs, 70(4), 516–527.
U.S. Department of Veterans Affairs. (July 27, 2018). Nicotine Use Disorders. U.S. Department of Veterans Affairs.
Hettema, J., & Steele, J. (2010). Meta-analysis of the Efficacy of Nicotine Replacement Therapy for Smoking Cessation: Limitations and Perspectives for Future Research. Nicotine & Tobacco Research, 12(9), 873–883.
van den Brand, I., et al. (2022). Efficacy of Motivational Interviewing and Brief Interventions on Tobacco Use Cessation Among Adults: A Systematic Review and Meta-Analysis. Johns Hopkins University.
van der Zwaluw, C. S., et al. (2022). Integrated Family Approach in Mental Health Care by Professionals and Family Members: Results of a Scoping Review and a Qualitative Study. Journal of Clinical Medicine, 11(9), 2447.
Boustani, M. M., et al. (2021). Family Involvement in Treatment and Recovery for Substance Use Disorders Among Adolescents and Young Adults: A Scoping Review. Clinical Child and Family Psychology Review, 24(3), 465–486.
Alcohol, Drug Abuse, and Mental Health Administration. (2001). 2 Settings, Levels of Care, and Patient Placement. National Center for Biotechnology Information.
McKay, J. R. (2021). Impact of Continuing Care on Recovery From Substance Use Disorders: The Need for Improved Research Methods. Psychiatric Services, 72(3), 281–289.
McKay, J. R., et al. Continuing Care Research: What We’ve Learned and Where We’re Going. Journal of Substance Abuse Treatment, 35(2), 86–98.
Substance Abuse and Mental Health Services Administration. Overview of substance use disorder (SUD) care clinical guidelines. Substance Abuse and Mental Health Services Administration.
National Association of Addiction Treatment Providers. NAATP Treatment Selection Guide. National Association of Addiction Treatment Providers.
University of Washington. Retention Toolkit: Family Involvement. University of Washington.
National Center for Biotechnology Information. (September 11, 2000). HEALTH EFFECTS – Toxicological Profile for Methylene Chloride. Agency for Toxic Substances and Disease Registry.